AgraQuest, a biotechnology company, has named Joel Jung as chief financial officer (CFO). Reporting directly to AgraQuest chief executive officer (CEO) Marcus Meadows-Smith, Jung will provide leadership to the AgraQuest finance and information technology groups.
Jung comes to AgraQuest with 14 years of experience as an executive in the life sciences and biotechnology industry, most recently as CFO of Celera Corporation where he led the finance and information technology groups in the spinoff of Celera from Applera Corporation. Prior to the spinoff, Jung served as vice president (VP), finance at Applera Corporation for the Celera Group. Jung’s background also includes working at Chiron Corporation for 11 years in several executive financial positions including VP and treasurer and VP, finance for Chiron’s blood testing division. He began his career at Varian Associates and Bank of America in various financial management positions.
Jung earned a BSc in Aeronautical Engineering from Purdue University and holds an MBA from the Haas School of Business at the University of California, Berkeley.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.